Chronic central administration of leptin reduces the expression of hepatic lipogenic genes and reduces TG content by stimulating hepatic sympathetic activity; this function requires PI3K signaling because the leptin-mediated impairment of PI3K signaling leads to hepatic steatosis without inducing obesity (Figure 2) (133). The gene discussed is LEP; the disease is fatty liver disease.